Drug Database
ZO

zolmitriptan (zolmitriptan, APR)

✓ Approved

tesa Labtec GmbH · HTR1B · Small Molecule

What is zolmitriptan?

zolmitriptan is a small molecule developed by tesa Labtec GmbH. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand Nameszolmitriptan, APR
Companytesa Labtec GmbH
Drug ClassSmall Molecule
Molecular TargetHTR1B, HTR1D
RouteOral (PO)
StatusApproved

Mechanism of Action

Molecular Targets

zolmitriptan acts on 2 molecular targets:

HTR1B5-hydroxytryptamine receptor 1B (HTR1DB, 5-HT1DB)
HTR1D5-hydroxytryptamine receptor 1D (HTR1DA, HT1DA)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

zolmitriptan is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Nervous system disordersMigraine✓ Approved

Related Research Articles

PubMedFrontiers in endocrinology2026-10-22

Diagnostic value of saline infusion test-derived biochemical parameters for primary aldosteronism subtyping.

Öztürk Yusuf Y, Karakurt Feridun F

Current clinical practice guidelines recommend adrenal venous sampling (AVS) for subtype classification in patients with primary aldosteronism (PA) who are candidates for adrenalectomy; however, AVS may be considered unnecessary in selected young patients with a high probability of unilateral disease. The additional diagnostic information provided by baseline and saline infusion test (SIT)-derived biochemical parameters when evaluated alongside clinical and radiological features remains uncertain. We aimed to compare the diagnostic performance of baseline and SIT-derived biochemical parameters for predicting unilateral PA and to evaluate the additional diagnostic information provided by each parameter when individually added to a common clinical-radiological framework. This retrospective study included 73 patients with PA (41 unilateral and 32 bilateral) who underwent successful AVS for subtype classification. Baseline plasma aldosterone concentration (PAC), baseline aldosterone-to-potassium ratio (APR), post-SIT PAC, SIT-derived APR, and the suppression index were evaluated. Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis, while their associations within a common clinical-radiological model were evaluated using multivariable logistic regression analysis. Post-SIT PAC and SIT-derived APR showed the highest numerical discriminative performance among the evaluated biochemical parameters for predicting unilateral PA (AUC = 0.817 and 0.837, respectively). Adding either parameter individually to the common clinical-radiological model significantly improved model fit (likelihood-ratio p = 0.014 and p = 0.028, respectively); however, the increases in AUC were not statistically significant (ΔAUC = 0.022, p = 0.185 and ΔAUC = 0.017, p = 0.107, respectively). Post-SIT PAC and SIT-derived APR were strongly correlated (Spearman's ρ = 0.983, p < 0.001), and their ROC-derived thresholds yielded concordant classifications in 97.3% of patients. Our findings suggest that post-SIT PAC shows useful discriminative performance for predicting unilateral PA and may contribute to subtype assessment when considered alongside clinical and radiological features. These findings require validation in independent cohorts.

PubMedBMC pregnancy and childbirth2026-10-21

Acceptability and uptake of COVID-19 vaccines among pregnant and lactating women seeking services at a tertiary public hospital in Kampala, Uganda.

Katana Elizabeth B EB, Odongpiny Eva Agnes Laker EAL, Simbwa Brenda N BN, Nsubuga Edirisa J EJ et al.

Globally, several vaccines, including COVID-19 vaccines, have been routinely recommended during pregnancy and lactation. However, data on COVID-19 vaccine acceptability and uptake among pregnant and lactating women are limited in Sub-Saharan Africa. While COVID-19 is no longer a public health emergency it is important to take stock of lessons learnt to prepare for future health threats including those that disproportionately affect pregnant/lactating women. We aimed to assess acceptability and uptake of COVID-19 vaccines among pregnant and lactating women in Uganda. This was a cross-sectional study conducted among 424 pregnant and lactating women, who were seeking maternal and child health care at Kawempe National Referral Hospital in Kampala conducted between May and July 2023. We obtained data on vaccine acceptability defined as willingness to accept vaccines using interviewer-administered questionnaires. In addition, we assessed vaccination status. Factors associated with COVID-19 vaccine acceptability and uptake were evaluated using modified Poisson regression. The mean age of the respondents was 26.9 years (SD = 5.7), ranging from 14 to 45 years. Among 424 respondents, 51.6% had received at least one dose of COVID-19 vaccine, 94.1% had received tetanus toxoid vaccine, and 48.4% regardless of their vaccination status, were willing to receive COVID-19 vaccines. Only 5/212(2.4%) had received COVID-19 vaccines while lactating with none having been received during pregnancy. Factors associated with COVID-19 vaccine uptake included history of testing for COVID-19 (aPR = 1.92, CI:1.46-2.54) and having a vaccinated household member (aPR = 1.34, CI:1.03-1.84). COVID-19 vaccine willingness was significantly associated with being a household head (aPR = 2.2, CI:1.12-4.27) and having a vaccinated household member (aPR = 1.33, CI:1.04-1.76). COVID-19 vaccine acceptance among pregnant and lactating women remains suboptimal despite high acceptance of other maternal vaccines. These findings highlight the need for targeted interventions to improve the acceptance and uptake of COVID-19 vaccines, during pregnancy and lactation. Strengthening risk communication, addressing safety concerns, and leveraging trusted sources of information may enhance vaccine confidence and improve uptake during pregnancy and lactation.

PubMedCardiovascular diabetology. Endocrinology reports2026-10-21

Multidomain Autonomic Dysfunction assessed with COMPASS-31 among patients with type 2 diabetes in Zanzibar: prevalence and associated factors.

Haji Hassan Thabit HT, Ali Ramla Muhidin RM, Khamis Ahmed Gharib AG, Ramaiya Kaushik K et al.

Autonomic dysfunction is an important but frequently under-recognized complication of type 2 diabetes mellitus (T2DM), particularly in settings where objective autonomic testing is not routinely available. The Composite Autonomic Symptom Score-31 (COMPASS-31) provides a practical symptom-based approach for assessing autonomic dysfunction across multiple domains. This study compared socioeconomic, lifestyle, and clinical characteristics among adults with T2DM in Zanzibar according to COMPASS-31-defined autonomic dysfunction and examined factors associated with its presence. This hospital-based cross-sectional study included 665 adults with T2DM attending the diabetes clinic at Mnazi Mmoja Hospital, Zanzibar. Autonomic symptoms were assessed using COMPASS-31, including the orthostatic intolerance, gastrointestinal, and bladder domains. Participants were classified as having autonomic dysfunction when they met the prespecified threshold for dysfunction in at least one assessed domain. Cardiovascular autonomic neuropathy (CAN) was assessed separately using standardized cardiovascular autonomic reflex tests performed with an automated CAN Analyzer and was not included in the COMPASS-31 composite outcome. Modified Poisson regression with robust variance estimation was used to calculate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Overall, 309 participants (46.5%) had COMPASS-31-defined autonomic dysfunction. Orthostatic intolerance was the most common domain, affecting 271 participants (40.8%), followed by gastrointestinal dysfunction in 177 (26.6%) and urinary dysfunction in 123 (18.5%). Separately, 305 participants (45.9%) met the analyzer-based criteria for CAN. In the multivariable analysis, autonomic dysfunction was more prevalent among participants without a family history of diabetes (aPR = 1.37, 95% CI: 1.16-1.61; p < 0.001), those with diabetes duration of ≥ 10 years (aPR = 1.45, 95% CI: 1.14-1.75; p < 0.001), those not using oral hypoglycemic agents (aPR = 1.66, 95% CI: 1.39-1.97; p < 0.001), and those who rarely consumed vegetables or consumed one portion per day (aPR = 1.79, 95% CI: 1.37-2.34; p < 0.001). Approximately half of the adults with T2DM in this tertiary-care population had COMPASS-31-defined autonomic dysfunction. Higher prevalence was associated with no family history of diabetes, longer diabetes duration, non-use of oral hypoglycemic agents, and lower vegetable intake. These findings highlight the potential value of symptom-based autonomic assessment and support further prospective research to better understand the clinical and lifestyle factors associated with autonomic dysfunction among adults with T2DM in Zanzibar.

PubMedDisability and health journal2026-10-20

Sexual and reproductive health service receipt among sexually active adolescent and young adult men by race and ethnicity and disability status.

Zionskowski Kelsey K, Hoyle Jessica J, Stevens J Dalton JD, Valentine Anne A et al.

Little is known about receipt of sexual and reproductive health (SRH) services among adolescent and young adult men with disabilities or by race and ethnicity. To examine differences in SRH service receipt by disability status, race, and ethnicity. We analyzed 2011-2019 National Survey of Family Growth data for sexually active men aged 15-25 (n = 4802). Groups reflected disability status and race and ethnicity, with non-Hispanic White men without disabilities as the reference. Modified Poisson regression was used to estimate adjusted prevalence ratios (aPRs) and 95% confidence intervals (CIs). Men with disabilities had similar or higher receipt of the SRH services examined. Compared with non-Hispanic White men without disabilities, non-Hispanic White men with disabilities had higher prevalence of STI testing (aPR, 1.80; 95% CI, 1.42-2.28) and being asked about type of sex (aPR, 1.58; 95% CI, 1.34-1.88). Hispanic men with disabilities had higher prevalence of being asked about type of sex (aPR, 2.10; 95% CI, 1.65-2.68) and receiving family planning services (aPR, 1.62; 95% CI, 1.30-2.01). Non-Hispanic Black men with disabilities had the highest service receipt, including STI testing (aPR, 2.56; 95% CI, 2.39-2.74) and being asked about condom use (aPR, 2.11; 95% CI, 1.65-2.70). Contrary to expectations, men with disabilities across racial and ethnic groups had higher SRH service receipt than non-Hispanic White men without disabilities. However, receipt remained low, with fewer than one-third receiving many recommended services, indicating missed opportunities to provide SRH care.

PubMedClinical toxicology (Philadelphia, Pa.)2026-10-20

Key agricultural pesticides responsible for acute pesticide poisoning in rural Sri Lanka - data to guide policy decisions.

Weerasinghe Manjula M, Karunarathne Ayanthi A, Eddleston Michael M

Acute pesticide poisoning is a major public health problem among agricultural communities in low-and middle-income countries. Using recent surveillance data, this analysis identifies key pesticides responsible for acute poisoning in Sri Lanka to inform timely, evidence-based policy interventions, with relevance to similar agricultural settings. We analyzed interim data from two prospective studies in rural Sri Lanka: 1) a suicide surveillance system (Oct 2023-Apr 2025) and 2) a community-based cohort of 1,200 pesticide sprayers (Jan-Dec 2024). Self-poisoning deaths were identified through police, coroner, and household follow-up data, while occupational poisoning was monitored through bimonthly cohort follow-up. Descriptive analyses were identified the pesticides and active ingredients responsible for poisoning events. Of 1,040 suicides identified, 236 (22.7%) involved pesticide ingestion; a single pesticide was confirmed in 184 (78.0%) of deaths. Insecticides accounted for 165/184 (89.7%) deaths, predominantly the carbamate carbosulfan (120/184, 65.2%; 95% Confidence Intervals (CI) 58.3-72.1) and organophosphorus profenofos (20/184, 10.9%; 95% CI 6.4-15.4), with a small proportion involving illegal pesticides (13/184, 7.1%) or herbicides (19/184, 10.3%). Pesticide sprayers reported 1,311 incidents of acute occupational pesticide poisoning, with 856 events occurring after use of a single identified pesticide. Insecticides were the most frequently implicated, led by profenofos (167/856, 19.5%; 95% CI 16.9-22.1), followed by herbicides, including pretilachlor (125/856, 14.6%; 95% CI 12.2-17.0) and glyphosate (81/856, 9.5%; 95% CI 7.5-11.5). These findings show that most pesticide poisoning is concentrated in two insecticides: carbosulfan and profenofos. Their continued prominence despite earlier regulatory actions suggests ongoing pesticide substitution and highlights the need for strengthened surveillance and targeted regulation. Carbosulfan and profenofos now account for most pesticide suicides in Sri Lanka, while profenofos is also the leading cause of acute occupational pesticide poisoning. These findings highlight the need for ongoing surveillance and timely regulatory review.

PubMedMalaria journal2026-10-19

The burden of malaria and associated factors among children aged 6-59 months in Mozambique: a nationwide cross‑sectional survey.

Adam Jovinary J, Munyangaju Isabelle I, Mwaisengela Syabo S, Mbawala Hawa H et al.

Malaria remains a major cause of morbidity and mortality among children under five years of age in Mozambique despite ongoing prevention and control interventions. Understanding the sociodemographic and household factors associated with malaria is essential for designing targeted public health strategies. This study aimed to determine the burden of malaria and identify its associated factors among children aged 6-59 months in Mozambique. This study used secondary data from the nationally representative 2022-23 Mozambique Demographic and Health Survey. A weighted sample of 4,016 children aged 6-59 months who underwent malaria rapid diagnostic testing (mRDT) was included in the analysis. Descriptive statistics were used to summarize participants' characteristics and estimate malaria prevalence. Associations between malaria and independent variables were assessed using modified Poisson regression with robust variance estimation. Adjusted prevalence ratios (APRs) with 95% confidence intervals (CIs) were reported. The overall prevalence of malaria among children aged 6-59 months was 32.3% (95% CI 29.1-35.7), with marked regional variation ranging from 0% in Cidade de Maputo to 54.7% in Nampula Province. In the multivariable analysis, malaria was independently associated with older child age (24-59 months) (APR = 1.58; 95% CI 1.42-1.76), rural residence (APR = 1.36; 95% CI 1.10-1.68), maternal primary education (APR = 2.06; 95% CI 1.52-2.81), informal maternal education (APR = 2.04; 95% CI 1.49-2.78), unimproved roof materials (APR = 1.29; 95% CI 1.07-1.56), middle wealth status (APR = 1.97; 95% CI 1.43-2.70), poor wealth status (APR = 2.41; 95% CI 1.73-3.37), anemia (APR = 2.89; 95% CI 2.42-3.45), malnutrition (APR = 1.10; 95% CI 1.02-1.21), residence in the central zone (APR = 1.92; 95% CI 1.41-2.64), and residence in the northern zone (APR = 3.06; 95% CI 2.24-4.19). Malaria remains highly prevalent among Mozambican children and is strongly associated with socioeconomic and household conditions. Bold, integrated, and equity-driven action that strengthens health systems, addresses social determinants, and protects the most vulnerable children are urgently required.

+9148 more articles available with a free account

Sign up free to view all articles →

Ask about zolmitriptan